A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-64619178, an Inhibitor of Protein Arginine Methyltransferase 5 (PRMT5) in Participants With Advanced Cancers
about
A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-64619178, an Inhibitor of Protein Arginine Methyltransferase 5 (PRMT5) in Participants With Advanced Cancers
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study of the Safety, Pharmac ...... icipants With Advanced Cancers
@en
type
label
A Study of the Safety, Pharmac ...... icipants With Advanced Cancers
@en
prefLabel
A Study of the Safety, Pharmac ...... icipants With Advanced Cancers
@en
P17
P6153
P1476
A Phase 1, First-in-Human, Ope ...... Subjects With Advanced Cancers
@en
P3098
NCT03573310
P580
2018-07-13T00:00:00Z
P582
2021-12-10T00:00:00Z